1)Gillenwater JY, Wein AJ:Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol 140:203-206, 1988
2)Ueda T, Sant GR, Hanno PM, et al:Interstitial cystitis and frequency-urgency syndrome(OAB syn-drome). Int J Urol 10(Suppl):S39-S48, 2003
3)Parsons CL, Lilly JD, Stein P:Epithelial dysfunction in nonbacterial cystitis(interstitial cystitis). J Urol 145:732-735, 1991
4)Kastrup J, Hald T, Larsen S, et al:Histamine content and mast cell count of detrusor muscle in patients with interstitial cystitis and other types of chronic cystitis. Br J Urol 55:495-500, 1983
5)Yoshimura N, Seki S, Chancellor MB, et al:Targeting afferent hyperexcitability for therapy of the painful bladder syndrome. Urology 59:61-67, 2002
6)Ueda T, Tamaki M, Ogawa O, et al:Over expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in patients with interstitial cystitis and bladder carcinoma. J Urol 167:347-351, 2002
7)本間之夫:間質性膀胱炎の診断:臨床的に何が重要か.Urology View 2:34-43,2004
8)Hanno PM, Wein AJ:Conservative therapy of interstitial cystitis. Semn Urol 9:143-147, 1991
9)Perez-Marrero R, Emerson LE, Feltis JT:A controlled study of dimethyl sulfoxide in interstitial cystitis. J Urol 140:36-39, 1988
10)Ueda T, Tamaki M, Ogawa O, et al:Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral IPD-1151T. J Urol 164:1917-1920, 2000